Skip to main content
Search
Main content
News

Eight UK DRI researchers feature on highly cited researchers 2024 list

Author

Molly Andrews

We are proud to announce that eight UK DRI researchers have featured in this year’s Highly Cited Researcher 2024 list from Clarivate. The annual ranking identifies researchers who have demonstrated significant influence in their chosen field or fields through the publication of multiple highly cited papers during the last decade.

The 2024 list recognises 6,886 researchers from 59 countries, whose citation records position them in the very highest strata of influence and impact. The UK is third in the world rankings with 563 researchers included this year.

The methodology that determines the “who’s who” of influential researchers is based on publications that rank in the top 1% by citations for field and publication year in the Web of Science™ citation index. Analysis is performed by bibliometric experts and data scientists at the Institute for Scientific Information™ at Clarivate. It also uses the tallies to identify the countries and research institutions where these scientific elite are based.

The eight researchers recognised from the UK DRI are:

Prof Bart De Strooper

Group Leader

Investigating the cellular reaction to amyloid beta and tau protein in Alzheimer's disease

Learn more Prof Bart De Strooper

Prof Paul Elliott

Group Leader

Using advanced methods in genetic, epidemiology and metabolic phenotyping to improve understanding of dementias

Learn more Prof Paul Elliott

Prof Sir John Hardy

Group Leader

Harnessing genetics to build a better understanding of dementia

Learn more Prof Sir John Hardy

Dr Axel Montagne

Group Leader

Exploring the link between cerebrovascular and inflamm-ageing to neurodegeneration and dementia

Learn more Dr Axel Montagne

Prof Josef Priller

Group Leader

Defining and modulating myeloid cell function in neurodegenerative diseases

Learn more Prof Josef Priller

Prof David Rubinsztein

Group Leader

Deciphering the link between neurodegeneration and autophagy

Learn more Prof David Rubinsztein

Prof Joanna Wardlaw

Group Leader and Clinical Director of the CVDR

Causes, mechanisms, clinical features, diagnosis, consequences, outcomes and treatment of cerebral small vessel disease focusing on clinical studies.

Learn more Prof Joanna Wardlaw

Prof Henrik Zetterberg

Group Leader

Pioneering the development of fluid biomarkers for dementia

Learn more Prof Henrik Zetterberg